Oncology Department, The 309th Hospital of Chinese People's Liberation Army, Beijing, China.
Thorac Cancer. 2017 Nov;8(6):729-733. doi: 10.1111/1759-7714.12506. Epub 2017 Sep 11.
A 57-year-old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptoms were significantly relieved. Treatment with apatinib mesylate represents a novel method of treatment for tracheal adenoid cystic carcinoma.
一位 57 岁男性 10 年前因气管腺样囊性癌入住我科,经化疗、放疗后停药,2016 年 12 月疾病复发,给予甲磺酸阿帕替尼(500mg/d)治疗后,患者症状明显缓解,甲磺酸阿帕替尼治疗气管腺样囊性癌为一种新的治疗方法。